CM Management’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Buy |
375,000
+100,000
| +36% | +$271K | 0.93% | 37 |
|
|
2025
Q1 | $932K | Hold |
275,000
| – | – | 0.94% | 39 |
|
|
2024
Q4 | $1.13M | Hold |
275,000
| – | – | 1.01% | 37 |
|
|
2024
Q3 | $685K | Buy |
275,000
+115,000
| +72% | +$286K | 0.55% | 51 |
|
|
2024
Q2 | $422K | Hold |
160,000
| – | – | 0.39% | 55 |
|
|
2024
Q1 | $330K | Buy |
160,000
+20,000
| +14% | +$41.2K | 0.28% | 61 |
|
|
2023
Q4 | $252K | Sell |
140,000
-94,803
| -40% | -$171K | 0.2% | 69 |
|
|
2023
Q3 | $322K | Hold |
234,803
| – | – | 0.34% | 55 |
|
|
2023
Q2 | $322K | Buy |
234,803
+3
| +0% | +$4 | 0.31% | 62 |
|
|
2023
Q1 | $554K | Hold |
234,800
| – | – | 0.66% | 43 |
|
|
2022
Q4 | $535K | Sell |
234,800
-10,200
| -4% | -$23.2K | 0.64% | 51 |
|
|
2022
Q3 | $676K | Buy |
245,000
+20,000
| +9% | +$55.2K | 0.75% | 47 |
|
|
2022
Q2 | $549K | Hold |
225,000
| – | – | 0.58% | 53 |
|
|
2022
Q1 | $887K | Buy |
225,000
+110,000
| +96% | +$434K | 0.74% | 47 |
|
|
2021
Q4 | $507K | Buy |
115,000
+40,000
| +53% | +$176K | 0.38% | 72 |
|
|
2021
Q3 | $464K | Hold |
75,000
| – | – | 0.35% | 77 |
|
|
2021
Q2 | $593K | Hold |
75,000
| – | – | 0.43% | 71 |
|
|
2021
Q1 | $803K | Buy |
+75,000
| New | +$803K | 0.6% | 66 |
|